These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5069316)

  • 21. The effect of fasting on galactosamine induced hepatitis in experimental animals.
    Pickering RW
    Arzneimittelforschung; 1977; 27(10):1992-6. PubMed ID: 579109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Specific hepatotoxic effect of D-galactosamine].
    Andreicut S; Kerekes M
    Morphol Embryol (Bucur); 1977; 23(3):221-5. PubMed ID: 142915
    [No Abstract]   [Full Text] [Related]  

  • 23. Protective effect of ammonium ions and L-norvaline on galactosamine induced liver injury.
    Pausch J; Wohleb B; Gerok W
    Hoppe Seylers Z Physiol Chem; 1977 May; 358(5):595-7. PubMed ID: 881166
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevention of galactosamine hepatitis using administration of D-galactose: significance of temporally limited UDP-galactose deficit for the induction of galactosamine hepatitis].
    Bauer C; Reutter W; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1502. PubMed ID: 4649767
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatoprotective effect of silymarin (carsil) on liver of D-galactosamine treated rats. Biochemical and morphological investigations.
    Tyutyulkova N; Tuneva S; Gorantcheva U; Tanev G; Zhivkov V; Chelibonova-Lorer H; Bozhkov S
    Methods Find Exp Clin Pharmacol; 1981; 3(2):71-7. PubMed ID: 7230979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma membrane of the regenerating rat liver. Plasma membrane as a key target organelle in galactosamine-induced hepatitis.
    Bachmann W; Reutter W
    Hoppe Seylers Z Physiol Chem; 1979 Jan; 360(1):81-7. PubMed ID: 216619
    [No Abstract]   [Full Text] [Related]  

  • 27. Protective effects of Alpha-tocopherol on the hepatotoxicity of D-galactosamine.
    Mihas AA; Doos W; Gibson RG; Hirschowitz BI
    Ala J Med Sci; 1976 Oct; 13(4):384-7. PubMed ID: 984338
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of liver-RES on toxic liver damage due to galactosamine.
    Grün M; Liehr H; Grün W; Rasenack U; Brunswig D
    Acta Hepatogastroenterol (Stuttg); 1974 Feb; 21(1):5-15. PubMed ID: 4450963
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication.
    Wands JR; Carter EA; Bucher NL; Isselbacher KJ
    Gastroenterology; 1979 Sep; 77(3):528-31. PubMed ID: 572315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
    Pickering RW; Lynn James GW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Status of the antioxidant, monooxygenase and humoral immune system of the body in d-galactosamine hepatitis].
    Korda MM
    Ukr Biokhim Zh (1978); 1996; 68(1):72-5. PubMed ID: 8755105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of uridine entrapped in liposomes in galactosamine-induced hepatitis.
    Mathias C; Dorai DT; Bachhawat BK
    Indian J Biochem Biophys; 1977 Jun; 14(2):142-6. PubMed ID: 590978
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of endotoxemia in galactosamine hepatitis by lactulose administered intravenously.
    Liehr H; Heine WD
    Hepatogastroenterology; 1981 Dec; 28(6):296-8. PubMed ID: 7345010
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism and clinical relevance of elevated levels of circulating asialoglycoproteins.
    Sawamura T; Shiozaki Y
    Targeted Diagn Ther; 1991; 4():215-34. PubMed ID: 1797157
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the mechanism of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase.
    Keppler D; Decker K
    Eur J Biochem; 1969 Sep; 10(2):219-25. PubMed ID: 5823097
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunopathology of acute galactosamine hepatitis in rats.
    Jonker AM; Dijkhuis FW; Kroese FG; Hardonk MJ; Grond J
    Hepatology; 1990 Apr; 11(4):622-7. PubMed ID: 2328956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Liver tissue enzymes in rats with galactosamine hepatitis during simultaneous administration of choline-orotate].
    Petzold H
    Cesk Gynekol; 1973 Jul; 27(5):290-3. PubMed ID: 4269483
    [No Abstract]   [Full Text] [Related]  

  • 38. [The importance of intestinal endotoxins for the rise of toxic liver lesions from galactosamine].
    Grün M; Liehr H; Rasenack U
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():251-60. PubMed ID: 800910
    [No Abstract]   [Full Text] [Related]  

  • 39. [Incorporation of 14-C-Glycine during galactosamine hepatitis of young and old rats (author's transl)a*].
    Platt D; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jul; 6(7):319-27. PubMed ID: 14537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of single or consecutive administration of T-2588 on hepatic-injured male rats].
    Shimotori T; Shibata T; Nakagawa S; Sato S; Nagai A; Yoneda T
    Jpn J Antibiot; 1986 Sep; 39(9):2307-23. PubMed ID: 3795480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.